Health Way has won the VBEF "Most Clinically Focused Product Award", and digital solutions have helped pharmaceutical companies break through
In 2025, big model technology will sweep across various industries with a breakthrough momentum; For healthcare, AI has become a new quality productivity that reshapes the industry landscape.
Yesterday, at the 2025 Future Medical and Pharmaceutical Top 100 Exhibition (VBEF), Health Road became the focus with its AI digital employees and digital breakthrough solutions for pharmaceutical companies - "AI digital employees" won the "Most Clinically Concerned Product" award. At the same time, Chen Jing, Executive Director and Senior Vice President of Health Road Group, made a stunning appearance with a full chain digital marketing solution, demonstrating the enormous value of AI digital employee applications and providing new momentum for pharmaceutical companies' transformation.
01Winning honors, AI digital employees were awarded the "Most Clinically Focused Product"
To discover innovative pioneers in the medical field, 2025VBEF has launched a special enterprise and product research award. After two months of industry research and comprehensive evaluation, the "AI Digital Employee" developed by Health Way stood out and won the "Most Clinically Focused Product Award".
AI digital employees are a multi role intelligent agent collaboration system for the entire medical scene in China, with three major characteristics: high intelligence (precise decision-making), high emotional intelligence (natural interaction), and high efficiency (automated processes). Its independently developed intelligent agent engine can dynamically optimize service processes, significantly improving efficiency.
Trial operation data shows that "AI digital employees" can reduce the cost of refined services by one order of magnitude per user for 7 × 24 hours. In the future, the company will also launch more scenario based applications such as AI pharmacy assistants and AI clinic assistants, and open them to industry partners.
02 Heavy debut, AI empowers pharmaceutical companies with digital marketing across the entire chain
During the same period, at the 2025 VBEF Pharmaceutical Enterprise Digital Marketing Forum, Chen Jing, Executive Director and Senior Vice President of Health Way Group, shared the breakthrough path of digital marketing. He pointed out that in the context of "strong regulation+technology driven", pharmaceutical companies need to rely on compliance data, full pipeline integration, and AI empowerment to achieve growth.
Chen Jing, Executive Director and Senior Vice President of Health Way Group
At present, Health Way has established a digital marketing model with Chinese characteristics, using AI big models and digital infrastructure as the intelligent marketing center, to create a multi-dimensional digital marketing system of "medical internet hospital+pharmacy terminal+traffic+e-commerce+private domain".
Through the full chain intelligent penetration of digital employees, digital marketing can achieve a leap from tool empowerment to ecological level solutions, drive multi scenario and global resonance, reshape the new paradigm of digital marketing in Chinese medicine, and create sustainable digital growth momentum for pharmaceutical companies.
At this VBEF exhibition, Health Way showcased the infinite possibilities of the deep integration of AI technology and medical health to the industry, driven by the dual engines of "AI digital employees" and digital solutions for pharmaceutical companies. In today's world where digitalization is sweeping the globe, the path of health is taking the form of an innovator, helping China's digital health and medical industry to leap from informatization to intelligence. In the future, the company will continue to promote the integration of intelligent technology and medical scenarios, driven by technology and centered on patients, working together with industry partners to create a new era of intelligent healthcare.